Also known as: MuDelta
Allergan (Licensor)Ironwood (Licensee)
Allergan grants Ironwood rights to co-promote Viberzi eluxadoline in the U.S.
Furiex Pharmaceuticals (Seller)Forest Laboratories (Buyer)
Forest acquiring Furiex for $95 per share in cash, or about $1.1 billion, plus contingent value rights valued at up to $360 million
Set Email Alert